- Home
- FRTT vs DYAI Comparison
FRTT vs DYAI Comparison
Compare FRTT & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRTT | DYAI |
|---|---|---|
| Founded | 2005 | 1979 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1M | 17.0M |
| IPO Year | 2025 | 2026 |
Fundamental Metrics
Financial Performance| Metric | FRTT | DYAI |
|---|---|---|
| Price | $0.48 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.2M | 91.3K |
| Earning Date | 11-14-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,090,345.00 |
| Revenue This Year | N/A | $113.16 |
| Revenue Next Year | N/A | $94.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $0.34 |
| 52 Week High | $3.92 | $1.60 |
Technical Indicators
Market Signals| Indicator | FRTT | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 28.08 | 41.29 |
| Support Level | N/A | $0.35 |
| Resistance Level | $1.03 | $0.48 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 1.99 | 23.83 |
Price Performance
Historical ComparisonAbout FRTT Fort Technology Inc. Common Shares
Fort Technology Inc is engaged the identification and evaluation of assets or business with a view to potentially acquire them or an interest therein by an option or any concomitant transaction.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.